NCT01163097View on ClinicalTrials.gov

Study to Characterize the Effect of Heparin on Palifermin Activity

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Oral Mucositis
Interventions
DRUG

Palifermin

40 µg/kg IV bolus injections for three consecutive days

DRUG

Heparin

Heparin continuous IV infusion

Trial Locations (1)

37920

New Orleans Center for Clinical Research (NOCCR), Knoxville

Sponsors
All Listed Sponsors
lead

Swedish Orphan Biovitrum

INDUSTRY